September 27, 2010 11:08 ET

Human Embryonic Stem Cells (hESC) to Grow 24.8% Annually From 2007 to 2015

ROCKVILLE, MD--(Marketwire - September 27, 2010) - has announced the addition of Industry Experts' new report "Human Embryonic Stem Cells (hESC) -- A Global Market Overview" to their collection of Biotechnology market reports. For more information, visit

Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood, and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.

Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and other cell technologies. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas. The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015.

The report reviews, analyzes and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 12 independent countries across North America -- United States, Canada and Mexico; Europe -- United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific -- India, China, Japan, Australia and Rest of Asia-Pacific.

This 216 page global market report includes 106 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments. The study also profiles 41 key global players and 55 major players across North America -- 28; Europe -- 15; Asia-Pacific -- 10 and Rest of World -- 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of hESCs. The global list of companies covers addresses, contact numbers and the website addresses of 184 companies.

For more information, visit

Contact Information